Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma / Judit Lazáry en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 6 (Junio)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 6 (Junio) . - pp. 1020-1028 Título : Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma Tipo de documento: texto impreso Autores: Judit Lazáry, Autor ; Nora Eszlari, Autor ; Gabriella Juhasz, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1020-1028 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Endocannabinoides, Epigenética, Neurodesarrollo, Receptor CB1, Medicina personalizada, Farmacogenómica Resumen: Fatty acid amide hydrolase (FAAH) inhibitors are addressed for promising anxiolytics, but human studies on genetically reduced FAAH activity, stress and affective phenotypes are scarce. Link: ./index.php?lvl=notice_display&id=26554 [artículo] Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma [texto impreso] / Judit Lazáry, Autor ; Nora Eszlari, Autor ; Gabriella Juhasz, Autor . - 2021 . - pp. 1020-1028. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 6 (Junio) . - pp. 1020-1028 Palabras clave: Endocannabinoides, Epigenética, Neurodesarrollo, Receptor CB1, Medicina personalizada, Farmacogenómica Resumen: Fatty acid amide hydrolase (FAAH) inhibitors are addressed for promising anxiolytics, but human studies on genetically reduced FAAH activity, stress and affective phenotypes are scarce. Link: ./index.php?lvl=notice_display&id=26554

---

1 (1 - 1 / 1)